Liver protector
Liver protector, licence 80068629: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- HeptaoWell, LiverWell
- Licence holder
- ApiWell Group Corp.
- NPN or DIN-HM
- 80068629
- Status
- Active licence
- Licence date
- 18 April 2016
- Revision date
- 9 June 2025
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Pueraria montana var. lobata (Willd.) Sanjappa & Pradeep: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Schisandra chinensis Source : Fruit Extraction ratio : 4:1 Dry plant equivalent : 480 milligramme | 120.0 milligramme | Not calculated |
| Pueraria montana var. lobata Source : Racine Extraction ratio : 5:1 Dry plant equivalent : 300 milligramme | 60.0 milligramme | Not calculated |
| Taraxacum mongolicum Source : Sommité en fleurs (herbe) Extraction ratio : 4:1 Dry plant equivalent : 240 milligramme | 60.0 milligramme | Not calculated |
| Artemisia scoparia Source : Sommité Extraction ratio : 10:1 Dry plant equivalent : 450 milligramme | 45.0 milligramme | Not calculated |
| Ziziphus jujuba Source : Fruit Extraction ratio : 10:1 Dry plant equivalent : 300 milligramme | 30.0 milligramme | Not calculated |
| Silybum marianum Source : Graine(s) Extraction ratio : 45:1 Dry plant equivalent : 3600 milligramme Potency : 80.0 % Silymarin | 80.0 milligramme | Not calculated |
| Panax notoginseng Source : Racine Extraction ratio : 5:1 Dry plant equivalent : 300 milligramme | 60.0 milligramme | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | minimum: 1.0 Tous les jours ; maximum: 4.0 Tous les jours |
Uses authorised in Canada
Combination of Traditional Chinese Medical Ingredients. Milk thistle is traditionally used in Herbal Medicine as a hepatoprotectant/liver protectant. Milk thistle is used in Herbal Medicine to help relieve digestive disturbances/dyspesia.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity, such as allergy, has been known to occur, in which case, discontinue use.
- Précautions et mises en garde
Consult a healthcare practitioner if you are taking other medications, or if you have hypertension. Keep out of reach of children. If symptoms persist or worsen, consult a healthcare practitioner. If you have hypokalemia, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you have a liver disorder or develop liver-related symptoms (e.g. abdominal pain, jaundice, dark urine). Due to possible estrogenic effect, men should consult a health care practitioner before use. If you are taking thyroid hormone replacement therapy, consult a health care practitioner prior to use.
- Contre-indications
Do not use if you are pregnant or breastfeeding. Do not use if you have excessive menstrual bleeding.
Source
Official Health Canada record, licence 80068629
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.